CIK 0001580149
- Non-accelerated filer
- Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 462510769
- Phone
- +1 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 4 Grant or award CEO & President acquired 149,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CEO & President acquired 41,506 shares (option exercise)
- 4 Open-market sale Director sold 10,984 shares at an average $6.13 ($67,288)
- 4 Open-market sale Director sold 10,984 shares at an average $8.52 ($93,581)
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,476 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 4,953 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,476 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Neuroscience Product Dev. gave up 2,476 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Neuroscience R&D gave up 2,476 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Liver Cirrhosis R&D gave up 2,476 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 34,240 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 43,578 shares (grant or award)
- 4 Grant or award EVP Neuroscience R&D acquired 39,624 shares (grant or award)
- 4 Grant or award Director acquired 34,240 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 39,624 shares (grant or award)
- 4 Grant or award EVP Neuroscience Product Dev. acquired 39,624 shares (grant or award)
- 4 Grant or award Director acquired 43,578 shares (grant or award)
Page 3 of 8 · 147 filings